We propose that this is because if antiviral inflammatory responses, for example IFN, are triggered at around the time of infection, either by exogenous signals, or by HIV-1 itself, then the activated antiviral effectors are too slow to inhibit that infection, that is, the expression of GFP from an integrated provirus. This evidence concerns the gene IFNA1 and infection.